300636.SZ · 同和药业
China A-shares · RS rating 65 · As of 2026-10-14
| Price | 6.83 CNY |
|---|---|
| 1-day change | -2.4% |
| RS rating (overall / 1M / 3M / 12M) | 65 / 74 / 62 / 37 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 20 / 23 / 11 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +7.8% |
| Distance from 52-week high | +22.4% |
| Market cap (USD) | $449.7M |